Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice
- 27 May 2015
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 110 (4) , 1-15
Abstract
Acute hyperglycemia during acute myocardial infarction is associated with worse myocardial injury and increased mortality. Using a mouse model of myocardial ischemia/reperfusion injury, we tested the hypothesis that acute hyperglycemia activates splenic leukocytes and subsequently exacerbates myocardial infarct size. We then examined whether the adverse effects of hyperglycemia could be attenuated by a potent anti-inflammatory agent (an agonist of the adenosine A2A receptor) administered immediately prior to reperfusion. C57BL6 (WT) mice underwent 30-min LAD occlusion and 60-min reperfusion with or without prior splenectomy. Acute hyperglycemia before ischemia increased myocardial infarct size (IS) by 43 % (p < 0.05). Splenectomy before ischemia did not change IS (vs. control, p = NS) but did serve to prevent the exacerbation of IS by hyperglycemia. Acute hyperglycemia activated splenic leukocytes by increasing formyl peptide receptor expression and reactive oxygen species production before ischemia, and enhanced splenic neutrophil release with resultant peripheral neutrophilia and increased myocardial neutrophil infiltration during reperfusion. Acute adoptive transfer of splenic leukocytes to splenectomized mice before ischemia restored the hyperglycemic exacerbation of infarct size. ATL146e, an adenosine 2A receptor (A2AR) agonist, abolished neutrophilia during reperfusion and reduced IS in hyperglycemic mice. ATL146e also reduced IS in splenectomized hyperglycemic mice with transfer of WT splenic leukocytes, but not with transfer of splenic leukocytes from A2AR knockout mice. Acute hyperglycemia prior to myocardial ischemia and reperfusion exacerbates IS by activating splenic leukocytes. ATL146e administered at reperfusion suffices to abrogate the hyperglycemic exacerbation of IS by acting on A2ARs on splenic leukocytes.Keywords
Funding Information
- University of Virginia Department of Surgery Startup Funds
- University of Virginia School of Medicine Collaborative Science Pilot Grant
- National Institutes of Health (HL 092305)
- National Institutes of Health (HL 092305)
This publication has 45 references indexed in Scilit:
- Relation of Admission Glucose Levels, Short- and Long-Term (20-Year) Mortality After Acute Myocardial InfarctionThe American Journal of Cardiology, 2013
- Stress hyperglycemia in acute ST-segment elevation myocardial infarction is a marker of left ventricular remodelingAcute Cardiac Care, 2013
- Endoscopic Time-Lapse Imaging of Immune Cells in Infarcted Mouse HeartsCirculation Research, 2013
- Optimized protocol for the isolation of spleen‐resident murine neutrophilsCytometry Part A, 2012
- Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Linfopenia post-reperfusión y obstrucción microvascular en el infarto agudo de miocardio con elevación del segmento STRevista Espanola de Cardiologia, 2009
- Glucose–insulin–potassium infusion in the management of acute hyperglycemia in patients with ST-segment elevation acute myocardial infarction: Lessons learned from randomized trialsJournal of Cardiology, 2009
- High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting PatientsThe Annals of Thoracic Surgery, 2008
- The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptideBMC Cell Biology, 2004
- Cardiac myocyte adenosine A2areceptor activation fails to alter cAMP or contractility: role of receptor localizationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002